Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Byrd

Showing results (811-820 of 903) with videos related to

Pageof 91
Sort By:
Leukemia|May 22, 2021
Genomic analysis of cellular hierarchy in acute myeloid leukemia using ultrasensitive LC-FACSeqCaner Saygin, Eileen Hu, Pu Zhang, et al.
Blood|November 17, 2021
PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemiaSwagata Goswami, Rajeswaran Mani, Jessica Nunes, et al.
Blood|December 27, 2019
Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 resultsJohn C Byrd, William G Wierda, Anna Schuh, et al.
British Journal of Haematology|December 4, 2018
Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysisJennifer R Brown, Javid Moslehi, Michael S Ewer, et al.
Cancer Discovery|December 5, 2020
Poor Survival and Differential Impact of Genetic Features of Black Patients with Acute Myeloid LeukemiaBhavana Bhatnagar, Jessica Kohlschmidt, Krzysztof Mrózek, et al.
The Lancet. Haematology|May 22, 2019
Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validationsJacob D Soumerai, Ai Ni, Mohamed Darif, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2021
Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT InhibitionPu Zhang, Lindsey T Brinton, Katie Williams, et al.
Blood|March 13, 2012
Regulation of acute graft-versus-host disease by microRNA-155Parvathi Ranganathan, Catherine E A Heaphy, Stefan Costinean, et al.
Blood|May 14, 2014
Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliteransRyan Flynn, Jing Du, Rachelle G Veenstra, et al.
Blood Advances|January 30, 2019
Selective targeting of NAMPT by KPT-9274 in acute myeloid leukemiaShaneice R Mitchell, Karilyn Larkin, Nicole R Grieselhuber, et al.
Pageof 91

Showing results (811-820 of 903) with videos related to

Sort By:
Pageof 91
Leukemia|May 22, 2021
Genomic analysis of cellular hierarchy in acute myeloid leukemia using ultrasensitive LC-FACSeqCaner Saygin, Eileen Hu, Pu Zhang, et al.
Blood|November 17, 2021
PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemiaSwagata Goswami, Rajeswaran Mani, Jessica Nunes, et al.
Blood|December 27, 2019
Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 resultsJohn C Byrd, William G Wierda, Anna Schuh, et al.
British Journal of Haematology|December 4, 2018
Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysisJennifer R Brown, Javid Moslehi, Michael S Ewer, et al.
Cancer Discovery|December 5, 2020
Poor Survival and Differential Impact of Genetic Features of Black Patients with Acute Myeloid LeukemiaBhavana Bhatnagar, Jessica Kohlschmidt, Krzysztof Mrózek, et al.
The Lancet. Haematology|May 22, 2019
Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validationsJacob D Soumerai, Ai Ni, Mohamed Darif, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2021
Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT InhibitionPu Zhang, Lindsey T Brinton, Katie Williams, et al.
Blood|March 13, 2012
Regulation of acute graft-versus-host disease by microRNA-155Parvathi Ranganathan, Catherine E A Heaphy, Stefan Costinean, et al.
Blood|May 14, 2014
Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliteransRyan Flynn, Jing Du, Rachelle G Veenstra, et al.
Blood Advances|January 30, 2019
Selective targeting of NAMPT by KPT-9274 in acute myeloid leukemiaShaneice R Mitchell, Karilyn Larkin, Nicole R Grieselhuber, et al.
Pageof 91